Equitable Health Research Licensing: Difference between revisions
Jump to navigation
Jump to search
(Created page with " =Description= Christian Wagner-Ahlfs, Peter Tinnemann, et al.: "The proposal puts forward the concept of "Equitable Licensing" an idea for how intellectual property rights ...") |
No edit summary |
||
| Line 12: | Line 12: | ||
# No premature IP transfer from publicly funded institutions to private industry" | # No premature IP transfer from publicly funded institutions to private industry" | ||
(http://healthresearchpolicy.org/node/167) | (http://healthresearchpolicy.org/node/167) | ||
=More Information= | |||
* paper, the EL for India?, http://papers.ssrn.com/sol3/papers.cfm?abstract_id=1621591 | |||
Latest revision as of 11:30, 9 February 2013
Description
Christian Wagner-Ahlfs, Peter Tinnemann, et al.:
"The proposal puts forward the concept of "Equitable Licensing" an idea for how intellectual property rights should be structured for R&D for NTDs. The proponents urge that the results of publicly funded R&D should be available for non-exclusive licensing.
The proposal relies on 3 IP principles:
- Non-exclusive use of publicly funded research results should be the default principle.
- Exclusive rights should become the exception, not the rule.
- No premature IP transfer from publicly funded institutions to private industry"
(http://healthresearchpolicy.org/node/167)
More Information
- paper, the EL for India?, http://papers.ssrn.com/sol3/papers.cfm?abstract_id=1621591